Anastasiya Koshkina
机构：Johnson & Johnson (United States)
发表论文 6 篇 · 总被引 71 次 · h-index 2
代表论文
- Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD (2024 · New England Journal of Medicine · 被引 65)
- Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3 , for Metabolic Dysfunction‐Associated Steatohepatitis (2024 · The Journal of Clinical Pharmacology · 被引 5)
- Sustained Action of Imapextide, A Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers (2025 · The Journal of Clinical Endocrinology & Metabolism · 被引 1)
- Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: a Two-Part, Randomized, Crossover Study (2026 · Journal of Cardiovascular Pharmacology)
- 846-P: Safety and Pharmacokinetics of MBX 1416, a Glucagon-Like Peptide 1 Receptor Antagonist, in Healthy Volunteers—A Phase 1 Randomized Trial (2025 · Diabetes)
- Reversal of the Anticoagulant Effect of Milvexian By 4-Factor PCC and rFVIIa in Healthy Participants (2024 · Blood)